or Try an Advanced Search...

    Technical Analysis for PSTX - Poseida Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 2.99 3.10% 0.09
    PSTX closed up 3.1 percent on Friday, May 31, 2024, on 30 percent of normal volume.
    Earnings due: Jun 14
    *** please verify all earnings dates ***
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Flat
    Historical PSTX trend table...
    Date Alert Name Type % Chg
    Crossed Above 20 DMA Bullish 0.00%
    Up 3 Days in a Row Strength 0.00%
    20 DMA Resistance Bearish 3.10%
    200 DMA Support Bullish 3.82%
    50 DMA Support Bullish 3.82%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 3.82%
    Gapped Down Weakness 3.82%
    Fell Below 20 DMA Bearish 4.55%
    MACD Bearish Signal Line Cross Bearish 4.55%
    Outside Day Range Expansion 4.55%
    Older End-of-Day Signals for PSTX ...

       Recent Intraday Alerts

    Alert Time
    20 DMA Resistance 2 days ago
    10 DMA Resistance 2 days ago
    Rose Above 20 DMA 2 days ago
    Rose Above Previous Day's High 2 days ago
    Rose Above 10 DMA 2 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    PSTX Chart by TradingView
    Basic chart:

    Profile

    Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in 2014 and is headquartered in San Diego, CA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Biopharmaceutical Clinical Medicine Life Sciences Solid Tumors Immune System Cancer Treatment Lymphoma Leukemia Chimeric Antigen Receptor T Cell Hematological Malignancies Chimeric Antigen Receptor Cellectis

    Is PSTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 30 Poseida Therapeutics Partners With Astellas: Worth Watching For Now
    May 14 Poseida Therapeutics GAAP EPS of -$0.25, revenue of $28.14M
    May 14 Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2024
    May 9 Poseida Highlights Strong Progress on Its Genetic Medicine Programs at the American Society for Gene and Cell Therapy 27th Annual Meeting
    May 3 Broker Revenue Forecasts For Poseida Therapeutics, Inc. (NASDAQ:PSTX) Are Surging Higher
    May 2 Xyphos and Poseida to develop allogeneic cell therapies for cancer
    May 1 Poseida gains on cell therapy pact with Astellas
    May 1 Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology
    May 1 Astellas adds to ‘off-the-shelf’ cell therapy capabilities with Poseida deal
    Apr 18 Poseida Therapeutics Announces Strong Lineup of Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
    See more PSTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.27
    52 Week Low 1.54
    Average Volume 570,844
    200-Day Moving Average 2.78
    50-Day Moving Average 2.77
    20-Day Moving Average 2.96
    10-Day Moving Average 2.99
    Average True Range 0.21
    RSI (14) 53.92
    ADX 17.65
    +DI 25.05
    -DI 21.56
    Chandelier Exit (Long, 3 ATRs) 2.93
    Chandelier Exit (Short, 3 ATRs) 3.21
    Upper Bollinger Bands 3.36
    Lower Bollinger Band 2.56
    Percent B (%b) 0.54
    BandWidth 27.00
    MACD Line 0.07
    MACD Signal Line 0.08
    MACD Histogram -0.0158
    Fundamentals Value
    Market Cap 285.92 Million
    Num Shares 95.6 Million
    EPS -1.54
    Price-to-Earnings (P/E) Ratio -1.94
    Price-to-Sales 6.92
    Price-to-Book 2.78
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.19
    Resistance 3 (R3) 3.18 3.10 3.15
    Resistance 2 (R2) 3.10 3.05 3.11 3.14
    Resistance 1 (R1) 3.05 3.02 3.08 3.06 3.13
    Pivot Point 2.97 2.97 2.99 2.98 2.97
    Support 1 (S1) 2.92 2.92 2.95 2.93 2.85
    Support 2 (S2) 2.84 2.89 2.85 2.84
    Support 3 (S3) 2.79 2.84 2.83
    Support 4 (S4) 2.80